Sucroferric oxyhydroxide chewable not checked
FollowEvery change as it happens, and a Monday email
Stage
No active trials
Next date
None yet
Trials
0 active
1 in total
Targets
—
None known yet
What this is
- How it works
- How it works isn't classified yet
- Tested for
- Smallpox
- Main trialPhase 4
- “An open-label, drug-drug interaction study with TPOXX and phosphate binders.”In the company’s words, NCT04485039 on ClinicalTrials.gov
- Other names
- Velphoro
Other drugs for Smallpox
- TecovirimatSIGA Technologies · Phase 2
- BNT166aBioNTech · Phase 2
- BSY001China National Biotec Group Company Limited · Phase 1
Coming up0
No dates coming up.
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials1
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 4Completed | 15 Dec 2022 | Drug-drug Interaction Study of TPOXX When Co-administered With Phosphate Binders |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026